• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Monocyte differentiation antigen CD14 (CD14)

Discover the exceptional quality of our Recombinant Human CD14 protein, designed to support your immunology research requirements. Expressed in E. coli, this full length mature protein (20-345aa) is equipped with an N-terminal GST-tag for seamless purification and detection. With a purity greater than 90% as determined by SDS-PAGE, our CD14 protein guarantees reliable and consistent outcomes. Explore the intricacies of monocyte differentiation antigens and their roles in immune responses using our premium recombinant protein. Available in both liquid and lyophilized powder forms, our Recombinant Human CD14 protein is a valuable addition to your immunology research arsenal.

ACP02786

Discover the exceptional quality of our Recombinant Human CD14 protein, designed to support your immunology research requirements. Expressed in E. coli, this full length mature protein (20-345aa) is equipped with an N-terminal GST-tag for seamless purification and detection. With a purity greater than 90% as determined by SDS-PAGE, our CD14 protein guarantees reliable and consistent outcomes.
Explore the intricacies of monocyte differentiation antigens and their roles in immune responses using our premium recombinant protein. Available in both liquid and lyophilized powder forms, our Recombinant Human CD14 protein is a valuable addition to your immunology research arsenal.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02786 Target NameCD14
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range20-345aaMol Weight62.2kDa
Protein LengthFull Length of Mature ProteinPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP08571
Background Information
  • Uniprot Id

    P08571

  • Target Species

    Human

  • Target Name

    CD14

  • Target Full Name

    Monocyte differentiation antigen CD14

  • Target Function

    Coreceptor for bacterial lipopolysaccharide. In concert with LBP, binds to monomeric lipopolysaccharide and delivers it to the LY96/TLR4 complex, thereby mediating the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Acts as a coreceptor for TLR2:TLR6 heterodimer in response to diacylated lipopeptides and for TLR2:TLR1 heterodimer in response to triacylated lipopeptides, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-).

  • Target Subcellular Location

    Cell membrane; Lipid-anchor, GPI-anchor. Secreted. Membrane raft. Golgi apparatus.

  • Target Tissue Specificity

    Detected on macrophages (at protein level). Expressed strongly on the surface of monocytes and weakly on the surface of granulocytes; also expressed by most tissue macrophages.

  • Target Research Area

    Immunology

  • Target Synonyms

    CD 14; CD_antigen=CD14; CD14; CD14 antigen; CD14 molecule; CD14_HUMAN; LPS-R; Mo2; Monocyte differentiation antigen CD14; Monocyte differentiation antigen CD14 urinary form; Monocyte differentiation antigen CD14; membrane-bound form; Myeloid cell specific leucine rich glycoprotein; Myeloid cell-specific leucine-rich glycoprotein

  • Target Background

    The protein encoded by this gene is a surface antigen that is preferentially expressed on monocytes/macrophages. It cooperates with other proteins to mediate the innate immune response to bacterial lipopolysaccharide, and to viruses. This gene has been identified as a target candidate in the treatment of SARS-CoV-2-infected patients to potentially lessen or inhibit a severe inflammatory response. Alternative splicing results in multiple transcript variants encoding the same protein.

Inquire Recombinant Human Monocyte differentiation antigen CD14 (CD14) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification